We are live on ! Find out more
IMMU

Immunomedics Inc
IMMU

Delisted

IMMU was delisted on the 22nd of October, 2020.

Back to rankings

79 hedge funds and large institutions have $68.9M invested in Immunomedics Inc in 2015 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 27 increasing their positions, 24 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

13% more repeat investments, than reductions

Existing positions increased: 27 | Existing positions reduced: 24

8% less call options, than puts

Call options by funds: $2.72M | Put options by funds: $2.96M

7% less funds holding

Funds holding: 85 → 79 (-6)

28% less first-time investments, than exits

New positions opened: 13 | Existing positions closed: 18

58% less capital invested

Capital invested by funds: $166M → $68.9M (-$97.1M)

Holders
79
Holders Change
-6
Holders Change %
-7.06%
% of All Funds
2.2%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
13
Increased
27
Reduced
24
Closed
18
Calls
$2.72M
Puts
$2.96M
Net Calls
-$241K
Net Calls Change
-$2.48M

Top Buyers

Rank Fund Capital Flow
1
O
OrbiMed
New York
+$8.48M
2
Balyasny Asset Management
Balyasny Asset Management
Illinois
+$5.12M
3
ACP
Acuta Capital Partners
California
+$4.37M
4
Goldman Sachs
Goldman Sachs
New York
+$713K
5
PAM
Panagora Asset Management
Massachusetts
+$535K

Top Sellers

Rank Fund Capital Flow
1
DM
Deerfield Management
New York
-$10.2M
2
WCM Investment Management
WCM Investment Management
California
-$8.09M
3
State of Wisconsin Investment Board
State of Wisconsin Investment Board
Wisconsin
-$6.09M
4
PA
Perceptive Advisors
New York
-$2.44M
5
CS
Candriam SCA
Luxembourg
-$1.34M
Name Holding Trade Value Shares
Change 		Change in
Stake
TRCT
76
Tower Research Capital (TRC)
New York
$1K -$11.7K -4,596 -87%
MI
77
Markston International
New York
$1K – – –
Manulife (Manufacturers Life Insurance)
78
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$113 +$4.82K +1,889 +3%
DM
79
Deerfield Management
New York
– -$10.2M -2,505,872 Closed
WCM Investment Management
80
WCM Investment Management
California
– -$8.09M -1,992,132 Closed
State of Wisconsin Investment Board
81
State of Wisconsin Investment Board
Wisconsin
– -$6.09M -1,500,000 Closed
PA
82
Perceptive Advisors
New York
– -$2.44M -600,000 Closed
CS
83
Candriam SCA
Luxembourg
– -$1.34M -330,000 Closed
BAMS
84
Bellevue Asset Management (Switzerland)
Switzerland
– -$1.22M -300,000 Closed
SFM
85
Sphera Funds Management
Israel
– -$995K -245,000 Closed
SGAM
86
Smith Group Asset Management
Texas
– -$857K -211,100 Closed
AIM
87
Ada Investment Management
New York
– -$306K -75,434 Closed
DWM
88
Destination Wealth Management
California
– -$145K -35,800 Closed
SCA
89
Secor Capital Advisors
New York
– -$126K -31,135 Closed
FHC
90
First Heartland Consultants
Missouri
– -$125 -30,695 Closed
Tudor Investment Corp
91
Tudor Investment Corp
Connecticut
– -$71K -17,600 Closed
Cambridge Investment Research Advisors
92
Cambridge Investment Research Advisors
Iowa
– -$64K -15,800 Closed
Canada Life
93
Canada Life
Manitoba, Canada
– -$26K -6,146 Closed
BRWM
94
B. Riley Wealth Management
Tennessee
– -$16K -4,070 Closed
Walleye Trading
95
Walleye Trading
New York
– -$13K -3,300 Closed
Invesco
96
Invesco
Georgia
– -$5K -1,242 Closed
VIA
97
Vantage Investment Advisors
Pennsylvania
– +$408 +160 New
1 2 3
4

IMMU Hedge Fund Activity: Q3 2015 in Review

79 of the 3,583 institutional investors tracked by Wall St. Rank reported a position in Immunomedics Inc (IMMU) for Q3 2015, worth a combined $68.9M — down 58% from $166M a quarter earlier.

Sellers outnumbered buyers: 18 funds closed out of IMMU and 13 opened new positions — a net loss of 5 holders — while 24 trimmed existing stakes and 27 added.

The largest buyer was OrbiMed, opening a new position worth an estimated $8.48M. The largest seller was Deerfield Management, exiting entirely with an estimated $10.2M sold.

  • 79 institutional investors held Immunomedics Inc (IMMU) as of Q3 2015, down from 85 in Q2 2015.
  • Funds reported $68.9M of Immunomedics Inc stock for Q3 2015, down 58% quarter-over-quarter.
  • 13 funds opened new Immunomedics Inc positions in Q3 2015 and 18 closed out, a net change of -5 holders.
  • The largest Immunomedics Inc buyer in Q3 2015 was OrbiMed, an estimated $8.48M added.
  • The largest Immunomedics Inc seller in Q3 2015 was Deerfield Management, an estimated $10.2M sold.

Based on aggregated 13F filings for Q3 2015.